The government's plan is for a drug system that operates more efficiently and that provides better drugs, faster. Changes to Ontario's Public Drug Programs have resulted in a new, faster and more transparent approval process and increased access to drugs.

• Recent reforms to Ontario Public Drug Programs have improved access to new drugs through a new conditional listing process that allows drugs to be conditionally listed for coverage by Ontario Public Drug Programs. As well, the government created a new process called Exceptional Access, a program that handles requests, on a case-by-case basis, for drugs that are not funded under the Ontario Drug Benefit Program. The process for requesting exceptional access is being streamlined to minimize the paperwork for physicians and make it more transparent to prescribers and patients.
  read about our Exceptional Access and Conditional Listings Progress  >>
• The government has introduced a rapid review process to significantly speed up the review of truly innovative drugs.
  read about our Rapid Review Process Progress  >>
• Ontario's publicly-funded drug programs are being aligned
  read about our Aligning Funding Policies progress  >>